Choreo, LLC Neogenomics Inc Transaction History
Choreo, LLC
- $6.84 Billion
- Q3 2024
A detailed history of Choreo, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Choreo, LLC holds 41,968 shares of NEO stock, worth $644,628. This represents 0.01% of its overall portfolio holdings.
Number of Shares
41,968
Previous 40,775
2.93%
Holding current value
$644,628
Previous $565,000
9.56%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
295Shares Held
125MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$302 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$216 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$106 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$101 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$100 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.93B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...